• About Us
  • Board of Advisors
  • Contact

MALARIA.com

A Malaria Information and Community Portal

  • Home
  • Malaria Overview
  • Malaria Research
  • News
  • Videos
  • Blogs
  • Malaria Q&A
  • Events
  • Jobs
Home / Archives for Antibiotics

Correlates of Inappropriate Prescribing of Antibiotics to Patients with Malaria in Uganda

January 27, 2014 By Malaria.com Leave a Comment

In many rural areas of Uganda, febrile patients presenting to health facilities are prescribed both antimalarials and antibiotics, contributing to the overuse of antibiotics. We identified the prevalence and correlates of inappropriate antibiotic management of patients with confirmed malaria. Methods We utilized individual outpatient data from 36 health centers from January to September … [Read more...]

Filed Under: Malaria Research Tagged With: Antibiotics, PLoS One, Uganda

Malarial Attack Recurring

June 14, 2012 By Malaria Q&A 2 Comments

QUESTION My Father aged 65 years was diagnosed with malaria 15 days back and was on medication. Fever was recurring frequently and he had developed a lung infection. Three days back fever stopped and did not occur for 2 days and malarial infection was reducing. Now the Fever has started coming but other parameters are normal. Can you please suggest what needs to be done? ANSWER If your … [Read more...]

Filed Under: Malaria Q&A Tagged With: Alu, Antibiotics, Artemisinin-based Combination Therapies, blood test, Coartem, diagnosis, Duo-Cotecxin, lung infection, Malaria Treatment

Naturally Drug-Resistant Cave Bacteria Possible Key to New Antibiotics

April 18, 2012 By Malaria.com Leave a Comment

New research findings suggest the key to finding a whole new variety of antibiotics to treat drug-resistant infections may lie with the resident bacteria in one of the most isolated caves in the world. The U.S. scientists who conducted the study say bacteria collected from Lechuguilla Cave in the state of New Mexico appear to possess an innate resistance to antibiotics, despite never having … [Read more...]

Filed Under: Malaria News Tagged With: Antibiotic Resistance, Antibiotics, Lechuguilla Cave, McMaster University, PLoS One, University of Akron

Bioengineered Antibiotic Could Lead to Improved Malaria Therapy

April 28, 2011 By Malaria.com Leave a Comment

A natural antibiotic long known for its power to fight bacteria, viruses and tumors has recently shown strength against malaria, but its extreme toxicity has impeded its use in medicine. However, a bioengineering breakthrough has opened a new avenue in the global battle against malaria. Scientists at Oregon State University have engineered several new versions of the antibiotic pactamycin … [Read more...]

Filed Under: Malaria News Tagged With: Antibiotics, Bioengineering, Chemistry & Biology Journal, Oregon State University, P. falciparum, Pactamycin, Taifo Mahmud

Anti-Infective Drugs Market to Reach $66 Billion by 2013, Says Report

October 15, 2010 By Malaria.com Leave a Comment

The anti-infective drugs market will jump to $66 billion by 2013, according to a recently published report. Anti-infective drugs include: anti-viral therapeutics, antibiotics, anti-fungal agents and prophylactic treatments such as vaccines. Six infectious diseases -- pneumonia, tuberculosis, diarrheal diseases, malaria, measles and HIV/AIDS -- account for half of all premature deaths worldwide. … [Read more...]

Filed Under: Malaria News Tagged With: Abraxis Bioscience, Acambis, Achillion, Acute Suppurative Thyroiditis, Adlyfe, Advanced Life Sciences Holdings, Affinium, Akonni Biosystems, Alnylam, Anti-fungal Agents, Anti-Infective Drugs, Anti-viral Therapeutics, Antibiotics, APP, Aquapharm Biodiscovery, Arbor Vita, Arpida, Avexa, Avian Bird Flu, Basilea, Baxter, Biophage Pharma, Blood-Borne Infections, CEL-SCI, Cerexa, Combimatrix, Complicated Skin and Skin Structure Infections, cSSSI, Cubist, Daiichi Sankyo, Diarrhea, Hospira, Idenix, Incyte, Influenza, Lymphadenitis, Malaria, Measles, Medivir, Meiji Holdings, MerLion, Mutabilis, Nanobio, Nanosphere, Nanoviricides, Novabay, Obetech, Optimer, Panacos, Pancreatitis, Paratek, Pharmasset, Pharyngotonsillitis, Pico, Pneumonia, Polymedix, Powdermed, Presidio, Progenics, Prophylactic Treatments, Protez, Reye's Syndrome, Rib-X, Ribomed, Sinusitis, Targanta, Theravance, Trius, Tuberculosis, Urinary Tract Infections, UTI, Vascular Infections, Vertex, Viral Encephalitis, West Nile Virus, X-GEN

Stay Informed

WWARN Corner

About WWARN

The WorldWide Antimalarial Resistance Network (WWARN) generates innovative resources and reliable evidence to inform the malaria community on the factors affecting the efficacy of antimalarial medicines. Learn more…

  • Fighting Malaria Requires Protecting the Effectiveness of Antimalarial Medicines
  • Data Sharing at IDDO
  • Evidence to inform equitable dosing in very young and malnourished children

More WWARN Stories...

Five Things You Might Not Know About Medicine Quality

The proliferation of poor quality medicines has been described as a global pandemic that threatens the lives of millions.1 It stands to reason that poor quality medicines are not going to improve anyone’s health, but how much do we really know about the quality of medicines used across the world? Here we examine five issues relating to medicine quality in an effort to show why we should all be paying more attention to a serious public health issue that is difficult to tackle and not yet fully understood.

How Can We Detect Poor Quality Medicines?

Finding out what medicines contain and investigating their packaging are vital steps in the fight against poor quality medicines, both substandard and falsified. Falsified medicines usually masquerade as real medicines by copying the appearance and packaging of the real product, but may not contain any of the same active ingredients, or in the correct amounts.

Challenges in Tackling the Issue of Poor Quality Medicines

There are many unresolved issues that impede the elimination of poor quality medicines, namely: (1) Progress impeded by confusion over definitions; Ensuring a market free of poor quality medicines; and the lack of global criminal laws.

Editorial

Antimicrobial Resistance: The Silent Threat in Malaria Eradication

By Bernard Owusu Agyware, Arielle Dolegui and Jesus Aquilar Malaria is a serious and sometimes deadly disease, affecting millions and claiming more than  600,000 lives worldwide each year in 2022 and 2021.1 Low and Middle-Income Countries (LMICs), particularly in Sub-Saharan Africa, disproportionately bear the greatest burden of malaria. The fight to eradicate this worrisome disease […]

  • Home
  • Malaria Overview
  • Malaria Research
  • News
  • Videos
  • Blogs
  • Malaria Q&A
  • Events
  • Jobs
  • About Us
  • Board of Advisors
  • Contact

Copyright © 2026 Malaria.com · Log in